International Clinical Trial: Tests to prove the efficacy and safety of the Hycos Membraderm gel product in humans suffering from acute or chronic wounds in infected or non-infected lesions

Geneva, June 4 -- International Clinical Trials Registry received information related to the study (RBR-478xd66) titled 'Tests to prove the efficacy and safety of the Hycos Membraderm gel product in humans suffering from acute or chronic wounds in infected or non-infected lesions' on May 22.

Study Type: Intervention

Primary Sponsor: Nipo Servicos Medicos SS Ltda

Condition: Pressure Ulcer C26.986

Intervention: To prove the efficacy and safety of the Hycos Membraderm gel product in humans affected by acute or chronic wounds in infected or uninfected lesions and demonstrate the action of the product in a faster regeneration of damaged or injured skin. This is a randomized controlled clinical study, carried out in a single group, in a s...